Longevity Health Holdings, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accounting Fees and Services
The following is a summary and description of fees incurred by Adeptus Partners, LLC (PCAOB ID: 3686) (“Adeptus”) located in Ocean, New Jersey for the fiscal years ended December 31, 2024 and 2023.
| Year Ended | ||
|---|---|---|
| Fee Category | December 31,2024 | December 31,2023 |
| Audit Fees (1) | $ 95,000 | $ 167,000 |
| Audit Related Fees (2) | — | — |
| Tax Fees (3) | — | — |
| All Other Fees (4) | — | — |
| Total | $ 95,000 | $ 167,000 |
(1)
Consists of fees for services related to the audit of the Company’s consolidated financial statements, quarterly reviews of the Company’s unaudited interim consolidated financial statements, and consultation on significant accounting matters.
(2)
Audit-related fees include attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards. We did not pay Adeptus for consultations concerning financial accounting and reporting standards for the fiscal years ended December 31, 2023 or 2024.
(3)
We did not pay Adeptus for tax planning and tax advice for the years ended December 31, 2023 or 2024.
(4)
We did not pay Adeptus for other services for the years ended December 31, 2023 or 2024.
Pre-Approval Policies and Procedures
The Audit Committee’s charter provides that the Audit Committee will pre-approve all auditing services and permitted non-audit services (including the fees and terms thereof) to be performed for the Company by its independent registered public accounting firm, as required by the applicable rules promulgated pursuant to the Exchange Act, subject to exceptions described in the Exchange Act, which are approved by the Audit Committee before the completion of the audit. The Audit Committee may delegate authority to one or more members of the Audit Committee, including the authority to grant pre-approvals of audit and permitted non-audit services, provided that decisions of such chair of the Audit Committee to grant pre-approvals are presented to the full Audit Committee at its next scheduled meeting.
Part IV
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.